Zumla Alimuddin, Rosenthal Philip J, Sam-Agudu Nada A, Ogoina Dimie, Mbala-Kingebeni Placide, Ntoumi Francine, Nakouné Emmanuel, Njouom Richard, Ndembi Nicaise, Mills Edward J, Muyembe-Tamfum Jean-Jacques, Nachega Jean B
Division of Infection and Immunity, Centre for Clinical Microbiology, University College London, United Kingdom.
National Institute for Health and Care Research (NIHR) Biomedical Research Centre, University College London Hospitals NHS Foundation Trust, London, United Kingdom.
Am J Trop Med Hyg. 2024 Oct 15;112(1):17-20. doi: 10.4269/ajtmh.24-0606. Print 2025 Jan 8.
On August 14, 2024, following a regional declaration by the Africa Centres for Disease Control and Prevention, the World Health Organization declared mpox a Public Health Emergency of International Concern, marking the second such declaration in two years. A series of outbreaks involving the more virulent clade I virus (compared to clade II, which caused a global outbreak in 2022), has now spread in 13 African countries, exposing the inadequacies of the public health infrastructure in these settings. There was significant investment during the 2022 global outbreak, but these efforts failed to address vaccine access and treatment in the Global South. Regulatory delays, unequal access to vaccines, and a lack of compassionate use treatments for severe cases have resulted in preventable cases and deaths, especially among vulnerable populations such as pregnant women, children, and the immunocompromised. The current outbreak also underscores critical knowledge gaps in our understanding of mpox, including its transmission, pathogenesis, and viral evolution. We join intensified calls for global solidarity and action to control mpox, emphasizing immediate containment measures and long-term local and international investment in African public health systems, to prevent future epidemics.
2024年8月14日,继非洲疾病控制与预防中心发布区域声明后,世界卫生组织宣布猴痘为“国际关注的突发公共卫生事件”,这是两年内的第二次此类声明。一系列涉及毒性更强的I型病毒(与2022年引发全球疫情的II型病毒相比)的疫情,现已在13个非洲国家蔓延,暴露出这些地区公共卫生基础设施的不足。在2022年全球疫情期间有大量投资,但这些努力未能解决全球南方地区的疫苗获取和治疗问题。监管延误、疫苗获取不平等以及缺乏针对重症病例的同情用药治疗,导致了可预防的病例和死亡,尤其是在孕妇、儿童和免疫功能低下等弱势群体中。当前疫情还凸显了我们在猴痘理解方面的关键知识空白,包括其传播、发病机制和病毒进化。我们加入到加强全球团结和采取行动控制猴痘的呼声中,强调立即采取遏制措施以及对非洲公共卫生系统进行长期的本地和国际投资,以预防未来的疫情。